Cellular Biology
Science NewsView All Science News
05/04/2018 | New featured articles from JAHA for May 1, 2018.
04/19/2018 | CIRCULATION RESEARCH Featured articles for April 2018. Every issue, the Editor-in-Chief selects articles of particular interest and impor...
03/27/2018 | CIRCULATION RESEARCH Featured articles for March 2018. Every issue, the Editor-in-Chief selects articles of particular interest and impor...
03/20/2018 | AHA Science News: Exclusive interviews, study results and more from Epidemiology and Prevention/Lifestyle 2018 Scientific Sessions in New...
BCVS 2018 Scientific Sessions
Basic Cardiovascular Sciences 2018 Scientific Sessions
July 30–Aug. 2, 2018
Grand Hyatt San Antonio
San Antonio, Texas
Networking for Professionals
About 1 in 4 stroke survivors suffers another one. Work with your patients to reduce their risk.
Get American Stroke Month Healthcare Professionals Resources
Join the conversation on Twitter at #StrokeMonth.
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Basic Cardiovascular Sciences (BCVS)
The American Heart Association (AHA) created the Council on Basic Cardiovascular Sciences (BCVS) in 1999 to promote research and education. Our goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease.
Ronglih Liao, PhD, FAHA
Chair, Council on Basic Cardiovascular Sciences
Council on Genomic and Precision Medicine (GPM)
The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.
Svati Shah, MD, MS, MHS, FAHA
Chair, Council on Genomic and Precision Medicine